[go: up one dir, main page]

SU1161089A1 - Method of determining death time - Google Patents

Method of determining death time Download PDF

Info

Publication number
SU1161089A1
SU1161089A1 SU833642199A SU3642199A SU1161089A1 SU 1161089 A1 SU1161089 A1 SU 1161089A1 SU 833642199 A SU833642199 A SU 833642199A SU 3642199 A SU3642199 A SU 3642199A SU 1161089 A1 SU1161089 A1 SU 1161089A1
Authority
SU
USSR - Soviet Union
Prior art keywords
activity
death
accuracy
protein
thromboplastic
Prior art date
Application number
SU833642199A
Other languages
Russian (ru)
Inventor
Дилявер Мирзаабдуллович Зубаиров
Радик Ахметович Якупов
Владимир Ильич Кузнецов
Original Assignee
Казанский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.С.В.Курашова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Казанский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.С.В.Курашова filed Critical Казанский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.С.В.Курашова
Priority to SU833642199A priority Critical patent/SU1161089A1/en
Application granted granted Critical
Publication of SU1161089A1 publication Critical patent/SU1161089A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

СПОСОБ ОПРЕДЕЛЕНИЯ ДАВНОСТИ НАСТУПЛЕНИЯ СМЕРТИ по активности ферментов в печени,о т л и ч а ющ и и с   тем, что, с целью повышени  точности определени , ведут определение активности 5-нуклеотидазы и тромбопластической активности и при уровне активности 5-нуклеотидазы от 108, 3 1 9,1 до 26,9 t 5,6 нкат/г белка определ ют давность смерти в первые сутки с точностью ± 1 час, при уровне тромбопластической активности от 0,7 t 0,03 до 0,5 ± ± 0,01 ед/г белка в первые трое суток посмертного периода определ ют давность смерти с точностью ± 6 ч, при тромбопластической активности от 0,5 ± 0,01 до 0,08 t 0,001 ед./г белка определ ют давность смерти в период от 3 до 7 cjrr с точностью ± 12 ч. слA METHOD FOR DETERMINING THE PRESSURE OF DEATH ATTITUDE by the activity of enzymes in the liver is about the fact that, in order to increase the accuracy of determination, they determine the activity of 5-nucleotidase and thromboplastic activity and at a level of 5-nucleotidase activity from 108, 3 1 9.1 to 26.9 t 5.6 nkat / g of protein determine the duration of death on the first day with an accuracy of ± 1 hour, with a level of thromboplastic activity of 0.7 t 0.03 to 0.5 ± 0, 01 units / g of protein in the first three days of the post-mortem period determine the duration of death with an accuracy of ± 6 hours, with thromboplastic activity from 0.5 ± 0.01 to 0.08 t 0.001 units / g of protein determines the duration of death in the period from 3 to 7 cjrr with an accuracy of ± 12 hours.

Description

0000

соwith

Claims (1)

СПОСОБ ОПРЕДЕЛЕНИЯ ДАВНОСТИ НАСТУПЛЕНИЯ СМЕРТИ по активности ферментов в печени, о т л и ч a torn и й с я тем, что, с целью повы шения точности определения, ведут определение активности 5-нуклеотидазы и тромбопластической активности и при уровне активности 5-нуклеотидазы от 108, 3 + 9,1 до 26,9 1 5,6 нкат/г белка определяют давность смерти в первые сутки с точностью + 1 час, при уровне тромбопластической активности от 0,7 + 0,03 до 0,5 + + 0,01 ед/г белка в первые трое суток посмертного периода определяют давность смерти с точностью + 6 ч, при тромбопластической активности от 0,5 + 0,01 до 0,08 + 0,001 ед./г белка определяют давность смерти в период от 3 до 7 сут с точностью ± 12 ч.THE METHOD FOR DETERMINING THE CHARACTERISTICS OF DEATH OF DEATH by the activity of enzymes in the liver, with the goal of determining the activity of 5-nucleotidase and thromboplastic activity and at a level of 5-nucleotidase activity 108, 3 + 9.1 to 26.9 1 5.6 nkat / g protein determine the duration of death on the first day with an accuracy of + 1 hour, with a level of thromboplastic activity from 0.7 + 0.03 to 0.5 + + 0 , 01 units / g of protein in the first three days of the post-mortem period, the death rate is determined with an accuracy of + 6 h, with a thromboplastic asset awn from 0.5 + 0.01 to 0.08 + 0.001 u / g protein was determined prescription death in 3 to 7 days to within ± 12 hours.
SU833642199A 1983-06-24 1983-06-24 Method of determining death time SU1161089A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU833642199A SU1161089A1 (en) 1983-06-24 1983-06-24 Method of determining death time

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU833642199A SU1161089A1 (en) 1983-06-24 1983-06-24 Method of determining death time

Publications (1)

Publication Number Publication Date
SU1161089A1 true SU1161089A1 (en) 1985-06-15

Family

ID=21081731

Family Applications (1)

Application Number Title Priority Date Filing Date
SU833642199A SU1161089A1 (en) 1983-06-24 1983-06-24 Method of determining death time

Country Status (1)

Country Link
SU (1) SU1161089A1 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Мельников Ю.Л., Жаров В.В. Судебно-медицинское определение времени наступлени смерти. М., Медицина 1978, с. 130-140. *

Similar Documents

Publication Publication Date Title
AU591696B2 (en) Acrylic acid/2-acrylamido-2-methylpropylsufonic acid/2- accrylamido-2-methylpropyl phosphonic acid polymers as scale and corrosion inhibitors
AU577870B2 (en) Liquid fuel corrosion inhibitor
AU7824381A (en) Telemetry system for centrifugal water chilling systems
IT1164156B (en) INHIBITORS OF THE ENZYME TRANSFORMING ANGIOTENSIN, CONSTITUTED BY AMINO ALKYLPHOSPHINIC ACIDS AND SIMILAR SUBSTITUTED AMINO PHOSPHINIC ACIDS
IE821168L (en) Encephalinase enzyme inhibiting compound
GB1468292A (en) Level indicating apparatus for pcm transmitting system
SU1161089A1 (en) Method of determining death time
FI850781L (en) FOERFARANDE FOER FRAMSTAELLNING AV AV L-CARNITIN PAO MIKROBIOLOGISKT SAETT.
AU553843B2 (en) L-lysine by fermentation
NO975504L (en) Method for detecting compounds that modulate the effects of the fat protein
AU6748681A (en) Control of doppler vor type navigation system
GB1486523A (en) S-acyl compounds and their use in determining lipase activity
IT8023768A0 (en) SALT OF (1-BENZYL-1H-INDAZOL-3-IL)-OXYACETIC ACID WITH LYSINE AND PROCEDURE FOR ITS PREPARATION.
NO871731L (en) PROCEDURE FOR SEPARATION OF INGREDIENTS IN A LIQUID CELL CULTURE MEDIUM.
AU4440785A (en) Preparation of l-phenylalanine from phenylpyruvic acid
ES8606946A1 (en) Peptide derivatives and their use as substrates in the quantitative determination of enzymes.
JPS5758191A (en) Active matric type liquid crystal indicator driving system
AU8225682A (en) Vanadium additive and grain refining of steel with vanadium
SU1147981A1 (en) Method of determination of sulpohydril groups in hemoproteins
AU577891B2 (en) Disk drive
Azelis et al. Progressive reduction in protein synthesis during involution and aging of the mouse thymus
EP0334526A3 (en) Condition connection for a parallel component processor and method
SE8002594L (en) Fermentable Acid Hydrolyzate as well as Fermentation Procedure
DK562181A (en) METHOD OF MICROORGANISM AND CULTURAL MEDIUM FOR THE PREPARATION OF AN A-4696G GLYCOPPEPTIDE OR A PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT, AND THE USE OF THE GLYCOPEPTIDE, AS A GROWTH PROMOTER
DE3585646D1 (en) FERMENTATION METHOD FOR THE PRODUCTION OF CARBONIC ACID ALKYL ESTERS.